@dansfera: The race is heating up! 🤯 There are two major narratives emerging from the FDA's push to accelerate new drug approvals. It looks like the core objective is directly tackling China's growing lead in Phase 1 studies and IND submissions. For research sites, this could translate directly into a massive increase in activity! The goal? Making the approval pathway significantly smoother for sponsors. Witnessing the gears turn in the world of medical innovation! #FDARules #DrugDevelopment #PharmaRace #ClinicalTrials #HealthNews